Michael Egan
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Dementia and Cognitive Impairment Research
Papers in
-
- Schizophrenia research and treatment 7
- Dementia and Cognitive Impairment Research 2
-
- Phosphodiesterase function and regulation 2
- Co-authors
- Terry E. Goldberg (6 shared papers)Tiffini Voss (10 shared papers)Yuki Mukai (7 shared papers)James Kost (9 shared papers)Christine Furtek (8 shared papers)Jeffrey L. Cummings (6 shared papers)Bruno Vellas (5 shared papers)Pierre N. Tariot (5 shared papers)
- Journals
- Biological Psychiatry (5 papers)Alzheimer s & Dementia (5 papers)Schizophrenia Research (4 papers)American Journal of Psychiatry (3 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Michael Egan
39 papers receiving 2.0k citations
Michael Egan's Hit Papers
Peers
Comparison fields: 5 of 130
- Biological Psychiatry 168
- Psychiatry and Mental health 500
- Physiology 719
- Pharmacology 402
- Cellular and Molecular Neuroscience 372
Countries citing papers authored by Michael Egan
This map shows the geographic impact of Michael Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Egan more than expected).
Fields of papers citing papers by Michael Egan
This network shows the impact of papers produced by Michael Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Egan. The network helps show where Michael Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease Hit paper breakdown → | 2018 | 503 |
| 2 | Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease Hit paper breakdown → | 2019 | 401 |
| 3 | 1999 | 284 | |
| 4 | 2000 | 142 | |
| 5 | 2003 | 80 | |
| 6 | 1980 | 71 | |
| 7 | 2019 | 66 | |
| 8 | 2020 | 65 | |
| 9 | 2008 | 60 | |
| 10 | 1985 | 58 | |
| 11 | 1994 | 52 | |
| 12 | 2018 | 45 | |
| 13 | 2013 | 45 | |
| 14 | 2010 | 35 | |
| 15 | 2012 | 20 | |
| 16 | 2024 | 11 | |
| 17 | 2020 | 10 | |
| 18 | 2000 | 9 | |
| 19 | 1993 | 8 | |
| 20 | 1994 | 8 |
About Michael Egan
Michael Egan is a scholar working on Psychiatry and Mental health, Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience and Strategy and Management, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (7 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Phosphodiesterase function and regulation (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Treatment of Major Depression (2 papers), Dementia and Cognitive Impairment Research (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Biological Psychiatry (168 citations), Psychiatry and Mental health (500 citations), Physiology (719 citations), Pharmacology (402 citations) and Cellular and Molecular Neuroscience (372 citations). Michael Egan has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Terry E. Goldberg, Tiffini Voss, Yuki Mukai, James Kost, Christine Furtek, Jeffrey L. Cummings, Bruno Vellas, Pierre N. Tariot, Erin Mahoney and Paul Aisen. Their work appears in journals such as Biological Psychiatry, Alzheimer s & Dementia, Schizophrenia Research, American Journal of Psychiatry and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.